These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1804094)

  • 1. Expression of tumour markers CA125, CASA and OSA in minimal/mild endometriosis.
    Ward BG; McGuckin MA; Ramm L; Forbes KL
    Aust N Z J Obstet Gynaecol; 1991 Aug; 31(3):273-5. PubMed ID: 1804094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of two new assays for tumor-associated antigens, CASA and OSA, found in the serum of patients with epithelial ovarian carcinoma--comparison with CA125.
    McGuckin MA; Layton GT; Bailey MJ; Hurst T; Khoo SK; Ward BG
    Gynecol Oncol; 1990 May; 37(2):165-71. PubMed ID: 1693126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum CA-125 and 17 beta-estradiol in patients with external endometriosis on danazol.
    Takahashi K; Musa AA; Nagata H; Kitao M
    Gynecol Obstet Invest; 1990; 29(4):301-4. PubMed ID: 2361639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic mass.
    Hogdall EV; Høgdall CK; Tingulstad S; Hagen B; Nustad K; Xu FJ; Bast RC; Jacobs IJ
    Int J Cancer; 2000 Nov; 89(6):519-23. PubMed ID: 11102897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum CA-125 levels in women with endometriosis.
    Fraser IS; McCarron G; Markham R
    Aust N Z J Obstet Gynaecol; 1989 Nov; 29(4):416-20. PubMed ID: 2534343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CEA, CA125, CA19-9 and human milk fat globule membrane antigen in ovarian tumours.
    Macdonald F; Bird R; Stokes H; Russell B; Crocker J
    J Clin Pathol; 1988 Mar; 41(3):260-4. PubMed ID: 3162916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New concepts in the pathophysiology and treatment of pelvic endometriosis.
    Brosens IA
    Contrib Gynecol Obstet; 1989; 17():36-43. PubMed ID: 2650998
    [No Abstract]   [Full Text] [Related]  

  • 8. [Usefulness of measurement of serum CA125 levels in diagnosing and treating endometriosis].
    Kobayashi H; Kanayama N; Hayata T; Kawashima Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jul; 39(7):1054-60. PubMed ID: 3475378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of gestrinone and danazol in infertile women with endometriosis.
    Ruiz-Velasco V; Arceo JR; Armesto A
    Int J Fertil Menopausal Stud; 1993; 38(1):22-7. PubMed ID: 8485607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma and peritoneal fluid levels of CA 125 in women with endometriosis.
    Dawood MY; Khan-Dawood FS; Ramos J
    Am J Obstet Gynecol; 1988 Dec; 159(6):1526-31. PubMed ID: 2462793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of mucin-specific monoclonal antibodies and lectins in the detection of tumor-associated serum markers in gynecological cancer.
    Devine PL; McGuckin MA; Ramm LE; Harada H; Ward BG
    Cancer Biochem Biophys; 1993 Sep; 13(4):221-38. PubMed ID: 8521372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of CA-125 in the diagnosis and management of endometriosis.
    Pittaway DE; Fayez JA
    Fertil Steril; 1986 Nov; 46(5):790-5. PubMed ID: 3465595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the origin and significance of serum CA-125 concentrations in 97 patients with endometriosis before, during, and after buserelin acetate, nafarelin, or danazol.
    Franssen AM; van der Heijden PF; Thomas CM; Doesburg WH; Willemsen WN; Rolland R
    Fertil Steril; 1992 May; 57(5):974-9. PubMed ID: 1533376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometriosis-associated infertility: evaluation of preoperative use of danazol, gestrinone, and buserelin.
    Donnez J; Nisolle-Pochet M; Casanas-Roux F
    Int J Fertil; 1990; 35(5):297-301. PubMed ID: 1980666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updating the clinical experience in endometriosis--the European perspective.
    Bromham DR; Booker MW; Rose GL; Wardle PG; Newton JR
    Br J Obstet Gynaecol; 1995 Oct; 102 Suppl 12():12-6. PubMed ID: 7577849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CA 125 levels in endometriosis patients before, during and after treatment with danazol or LHRH agonists.
    Acien P; Shaw RW; Irvine L; Burford G; Gardner R
    Eur J Obstet Gynecol Reprod Biol; 1989 Sep; 32(3):241-6. PubMed ID: 2676640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of danazol in the management of endometriosis.
    Young MD; Blackmore WP
    J Int Med Res; 1977; 5 Suppl 3():86-91. PubMed ID: 913886
    [No Abstract]   [Full Text] [Related]  

  • 18. CAM26, CAM29 and mucin-like carcinoma associated antigen in epithelial ovarian cancer.
    Ferdeghini M; Gadducci A; dell'Hoste M; Prontera C; Ceccarini T; Rispoli G; Bianchi R; Fioretti P
    Eur J Gynaecol Oncol; 1990; 11(5):395-401. PubMed ID: 1965803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The morphologic effect of short-term medical therapy of endometriosis.
    Brosens IA; Verleyen A; Cornillie F
    Am J Obstet Gynecol; 1987 Nov; 157(5):1215-21. PubMed ID: 3688077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CA-125 is an effective marker for patients with external endometriosis and on danazol: case reports.
    Takahashi K; Yoshino K; Nagata H; Kusakari M; Kitao M
    Fertil Steril; 1988 Jul; 50(1):173-5. PubMed ID: 3164281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.